RxDoctor Payments Data

Hannah Morrison

Nurse Practitioner · Medina, OHNPI 1851869564

Payments from drug & device makers

$1,576in general payments, 2019–2025

Across 92 payments — averaging $17.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$506
  • AstraZeneca$366
  • Sanofi$167
  • Novartis$151
  • Regeneron Healthcare Solutions, Inc.$73
  • Genentech USA, Inc.$70
  • plus $243 from 7 others

What the payments were for

  • Food & beverage$1,576100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,576 in reported general payments places this provider in the 85th percentile of 4,700 nurse practitioner providers in Ohio.

See all nurse practitioner providers in Ohio

Medicare billing

Part B allowed, 2024
$13,116
Medicare patients
107
Services billed
393

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Breo ElliptaFluticasone/Vilanterol29$29,277
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$25,099
Advair HfaFluticasone Propion/Salmeterol11$5,820
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate15$5,009
Epinephrine15$4,145
Ipratropium Bromide58$2,480
Montelukast Sodium186$2,300
Fluticasone-SalmeterolFluticasone Propion/Salmeterol14$2,072
Albuterol Sulfate HfaAlbuterol Sulfate62$2,008
Levocetirizine Dihydrochloride78$1,811
Azelastine Hcl43$1,698
Flunisolide12$1,028
Fluticasone Propionate39$695
Prednisone15$27

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKBreo Ellipta, Trelegy Ellipta$506$54,37655 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,700 nurse practitioner providers in Ohio.

Other nurse practitioner in Medina

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →